Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

Cytiva is expanding its Xcellerex X-platform portfolio with the addition of 500L and 2,000L bioreactors.

In this case study, analytical method optimization with Fusion QbD software for a synthetic peptide and small molecule API is ...

Carbogen Amcis has been granted a GMP certificate for its 9,500m² Saint-Beauzire facility, supporting a wide range of ...

BioDuro has opened a new lab in Shanghai, China for highly potent compound synthesis at the hundred-gram scale.

Merck will manufacture and commercialize HRS-5346 worldwide.

The launch of Denarase High Salt GMP-grade marks a significant milestone in c-LEcta’s commitment to providing innovative solutions for the biopharmaceutical industry. This engineered enzyme ...